This report contains market size and forecasts of Levosimendan in global, including the following market information:
Global Levosimendan Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Levosimendan Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Levosimendan companies in 2021 (%)
The global Levosimendan market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ≥99.5% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Levosimendan include Tenax Therapeutics, Shengnuo Biotechnology, Olon, Melody Healthcare, Precise Group, Alven Laboratories, Fermion, Aspen and Enomark and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Levosimendan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Levosimendan Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Levosimendan Market Segment Percentages, by Type, 2021 (%)
Purity ≥99.5%
Purity ≥99.9%
Global Levosimendan Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Levosimendan Market Segment Percentages, by Application, 2021 (%)
Injection Solution
Oral Liquid
Global Levosimendan Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Levosimendan Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Levosimendan revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Levosimendan revenues share in global market, 2021 (%)
Key companies Levosimendan sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Levosimendan sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tenax Therapeutics
Shengnuo Biotechnology
Olon
Melody Healthcare
Precise Group
Alven Laboratories
Fermion
Aspen
Enomark
Sirnaomics